Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Inpixon buy geldnutzer

Start price
€102.75
24.01.21 / 50%
Target price
€150.00
Performance (%)
8.76%
End price
€111.75
07.02.21
Summary
This prediction ended on 07.02.21 with a price of €111.75. With a performance of 8.76%, the BUY prediction by geldnutzer for Inpixon closed with a slight gain. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Inpixon - - - -
iShares Core DAX® -0.870% -1.700% 10.560% 13.129%
iShares Nasdaq 100 -5.561% -3.604% 34.335% 39.856%
iShares Nikkei 225® -6.138% -7.732% 16.215% 0.044%
iShares S&P 500 -3.141% -2.011% 24.534% 39.859%

According to geldnutzer what are the pros and cons of Inpixon for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Standard Investments for future growth
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Growths faster than the competition
Sustainability is important
Very Future proof/growth oriented business model
Cons
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Dependend from some customers or products
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand

Comments by geldnutzer for this prediction

In the thread Inpixon diskutieren
Prediction Buy
Perf. (%) 8.76%
Target price 2.000
Change
Ends at

Buy mit Kursziel 2,0

In the thread Trading Inpixon
Prediction Buy
Perf. (%) 8.76%
Target price 2.000
Change
Ends at

Buy beendet

Stopped prediction by geldnutzer for Inpixon

Inpixon

Start price
Target price
Perf. (%)
€111.75
07.02.21
€22.50
07.02.22
-74.54%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group